Cargando…
The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
PURPOSE: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is often difficult due to the wide variety of symptoms and overlaps in the similar clinical courses and neurological findings. The purpose of this study was to evaluate the utility of white matter (WM) atrop...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459051/ https://www.ncbi.nlm.nih.gov/pubmed/26082887 http://dx.doi.org/10.1016/j.nicl.2014.02.009 |
_version_ | 1782375159805509632 |
---|---|
author | Sakurai, Keita Imabayashi, Etsuko Tokumaru, Aya M. Hasebe, Shin Murayama, Shigeo Morimoto, Satoru Kanemaru, Kazutomi Takao, Masaki Shibamoto, Yuta Matsukawa, Noriyuki |
author_facet | Sakurai, Keita Imabayashi, Etsuko Tokumaru, Aya M. Hasebe, Shin Murayama, Shigeo Morimoto, Satoru Kanemaru, Kazutomi Takao, Masaki Shibamoto, Yuta Matsukawa, Noriyuki |
author_sort | Sakurai, Keita |
collection | PubMed |
description | PURPOSE: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is often difficult due to the wide variety of symptoms and overlaps in the similar clinical courses and neurological findings. The purpose of this study was to evaluate the utility of white matter (WM) atrophy for the diagnosis of patients with clinically diagnosed CBD (corticobasal syndrome, CBS) and PSP (Richardson’s syndrome, RS). METHODS: We randomly divided the 3D T1-weighted MR images of 18 CBS patients, 33 RS patients, and 32 age-matched controls into two groups. We obtained segmented WM images in the first group using Voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) based on statistical parametric mapping (SPM) 8 plus diffeomorphic anatomical registration through exponentiated Lie algebra. A target volume of interest (VOI) for disease-specific atrophy was subsequently determined in this group using SPM8 group analyses of WM atrophy between patients groups and controls. We then evaluated the utility of these VOIs for diagnosing CBS and RS patients in the second group. Z score values in these VOIs were used as the determinant in receiver operating characteristic (ROC) analyses. RESULTS: Specific target VOIs were determined in the bilateral frontal subcortical WM for CBS and in the midbrain tegmentum for RS. In ROC analyses, the target VOIs of CBS and RS compared to those of controls exhibited an area under curve (AUC) of 0.99 and 0.84, respectively, which indicated an adequate diagnostic power. The VOI of CBS revealed a higher AUC than that of RS for differentiating between CBS and RS (AUC, 0.75 vs 0.53). CONCLUSIONS: Bilateral frontal WM volume reduction demonstrated a higher power for differentiating CBS from RS. This VOI analysis is useful for clinically diagnosing CBS and RS. |
format | Online Article Text |
id | pubmed-4459051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-44590512015-06-16 The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome Sakurai, Keita Imabayashi, Etsuko Tokumaru, Aya M. Hasebe, Shin Murayama, Shigeo Morimoto, Satoru Kanemaru, Kazutomi Takao, Masaki Shibamoto, Yuta Matsukawa, Noriyuki Neuroimage Clin Regular Article PURPOSE: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is often difficult due to the wide variety of symptoms and overlaps in the similar clinical courses and neurological findings. The purpose of this study was to evaluate the utility of white matter (WM) atrophy for the diagnosis of patients with clinically diagnosed CBD (corticobasal syndrome, CBS) and PSP (Richardson’s syndrome, RS). METHODS: We randomly divided the 3D T1-weighted MR images of 18 CBS patients, 33 RS patients, and 32 age-matched controls into two groups. We obtained segmented WM images in the first group using Voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) based on statistical parametric mapping (SPM) 8 plus diffeomorphic anatomical registration through exponentiated Lie algebra. A target volume of interest (VOI) for disease-specific atrophy was subsequently determined in this group using SPM8 group analyses of WM atrophy between patients groups and controls. We then evaluated the utility of these VOIs for diagnosing CBS and RS patients in the second group. Z score values in these VOIs were used as the determinant in receiver operating characteristic (ROC) analyses. RESULTS: Specific target VOIs were determined in the bilateral frontal subcortical WM for CBS and in the midbrain tegmentum for RS. In ROC analyses, the target VOIs of CBS and RS compared to those of controls exhibited an area under curve (AUC) of 0.99 and 0.84, respectively, which indicated an adequate diagnostic power. The VOI of CBS revealed a higher AUC than that of RS for differentiating between CBS and RS (AUC, 0.75 vs 0.53). CONCLUSIONS: Bilateral frontal WM volume reduction demonstrated a higher power for differentiating CBS from RS. This VOI analysis is useful for clinically diagnosing CBS and RS. Elsevier 2014-02-27 /pmc/articles/PMC4459051/ /pubmed/26082887 http://dx.doi.org/10.1016/j.nicl.2014.02.009 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Regular Article Sakurai, Keita Imabayashi, Etsuko Tokumaru, Aya M. Hasebe, Shin Murayama, Shigeo Morimoto, Satoru Kanemaru, Kazutomi Takao, Masaki Shibamoto, Yuta Matsukawa, Noriyuki The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome |
title | The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome |
title_full | The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome |
title_fullStr | The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome |
title_full_unstemmed | The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome |
title_short | The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome |
title_sort | feasibility of white matter volume reduction analysis using spm8 plus dartel for the diagnosis of patients with clinically diagnosed corticobasal syndrome and richardson’s syndrome |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459051/ https://www.ncbi.nlm.nih.gov/pubmed/26082887 http://dx.doi.org/10.1016/j.nicl.2014.02.009 |
work_keys_str_mv | AT sakuraikeita thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT imabayashietsuko thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT tokumaruayam thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT hasebeshin thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT murayamashigeo thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT morimotosatoru thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT kanemarukazutomi thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT takaomasaki thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT shibamotoyuta thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT matsukawanoriyuki thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT sakuraikeita feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT imabayashietsuko feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT tokumaruayam feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT hasebeshin feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT murayamashigeo feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT morimotosatoru feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT kanemarukazutomi feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT takaomasaki feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT shibamotoyuta feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome AT matsukawanoriyuki feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome |